Medbox was most likely offered the same opportunity as ERBB to own the patent that was granted years before Medbox obtained their own,and as a result, just on the news release of an agreement reached between ERBB and the patent holder, Medbox is dropping like a rock in water, and when ERBB signs on the dotted line, it's all over for Medbox, and ERBB will fly.
This is a crime for all MDBX shareholders that Medbox was so lame in not realizing that they will in fact have to obtain licensing or be sued by ERBB. That said, Medbox will tank drastically when the contracts are signed.
What kind of lawyers would give the CEO such confidence in their own patent not to see that they will have to remove the biometrics from their machines as it all comes under the original, which was years before MDBX was granted. No matter how different they think their machines are from ZaZZZ, as long as they have biometrics on board, they will have to pay the piper. Take your profits if any, and run. ERBB will outpace MDBX in a few months, and be the next giant in the industry. Everyone out there has to go through ERBB to use these machines with biometric technology. How's that for poor judgment by management!?
